Announcements Trials
Browse Landscape

Phase

Phase 2 47Phase 1 13Phase 3 10Phase 4 6Phase 1/2 6Phase NA 2

Status

Unknown 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 3Lymphoid 2Breast 2Plasma cell 1

Conditions

Breast Neoplasms 2

Interventions

Exercise 126Surveys and Questionnaires 60Standard of Care 59Early Intervention, Educational 55Methods 54Educational Status 53Magnetic Resonance Spectroscopy 50Acupuncture Therapy 48Blood Specimen Collection 46Radiotherapy 39Mammography 39Control Groups 35Counseling 32Therapeutics 30Practice Guidelines as Topic 30Cyclophosphamide 29Biopsy 28Sentinel Lymph Node Biopsy 27Psychiatric Rehabilitation 27Neoadjuvant Therapy 24Yoga 23Mastectomy, Segmental 23Resistance Training 22Interviews as Topic 21Surgical Procedures, Operative 19Palliative Care 19High-Energy Shock Waves 19Trastuzumab 18Doxorubicin 18Cognitive Behavioral Therapy 18

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × liposomal doxorubicin × Breast × Clear all
NCT05656079 2022-12-19

easy laugh

Shanghai Pudong Hospital

Phase NA Unknown
204 enrolled
Breast

Breast Neoplasms

NCT03221881 2017-07-19

Neoadjuvant Chemotherapy With a Combination of Pegylated Liposomal Doxorubicin (Caelyx®) and Paclitaxel in Breast Cancer

Hebei Medical University Fourth Hospital

Phase NA Completed
100 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡